|
1
|
Phinney DG and Prockop DJ: Concise review:
mesenchymal stem/multipotent stromal cells: the state of
transdifferentiation and modes of tissue repair - current views.
Stem Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesen-chymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han KH, Ro H, Hong JH, Lee EM, Cho B, Yeom
HJ, Kim MG, Oh KH, Ahn C and Yang J: Immunosuppressive mechanisms
of embryonic stem cells and mesenchymal stem cells in alloimmune
response. Transpl Immunol. 25:7–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagaya N, Fujii T, Iwase T, Ohgushi H,
Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K and Kitamura S:
Intravenous administration of mesenchymal stem cells improves
cardiac function in rats with acute myocardial infarction through
angio-genesis and myogenesis. Am J Physiol Heart Circ Physiol.
287:H2670–H2676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tatebe M, Nakamura R, Kagami H, Okada K
and Ueda M: Differentiation of transplanted mesenchymal stem cells
in a large osteochondral defect in rabbit. Cytotherapy. 7:520–530.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Im GI, Kim DY, Shin JH, Hyun CW and Cho
WH: Repair of cartilage defect in the rabbit with cultured
mesenchymal stem cells from bone marrow. J Bone Joint Surg Br.
83:289–294. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bensaïd W, Oudina K, Viateau V, Potier E,
Bousson V, Blanchat C, Sedel L, Guillemin G and Petite H: De novo
reconstruction of functional bone by tissue engineering in the
metatarsal sheep model. Tissue Eng. 11:814–824. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harris CT and Cooper LF: Comparison of
bone graft matrices for human mesenchymal stem cell-directed
osteogenesis. J Biomed Mater Res A. 68:747–755. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Horwitz EM, Gordon PL, Koo WK, Marx JC,
Neel MD, McNall RY, Muul L and Hofmann T: Isolated allogeneic bone
marrow-derived mesenchymal cells engraft and stimulate growth in
children with osteogenesis imperfecta: Implications for cell
therapy of bone. Proc Natl Acad Sci USA. 99:8932–8937. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawada H, Fujita J, Kinjo K, Matsuzaki Y,
Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, et
al: Nonhematopoietic mesenchymal stem cells can be mobilized and
differentiate into cardiomyocytes after myocardial infarction.
Blood. 104:3581–3587. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Damme A, Vanden Driessche T, Collen D
and Chuah MK: Bone marrow stromal cells as targets for gene
therapy. Curr Gene Ther. 2:195–209. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Allison M: Genzyme back Osiris, despite
Prochymal flop. Nat Biotechnol. 27:966–967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang XP, Sun Z, Miyagi Y, McDonald
Kinkaid H, Zhang L, Weisel RD and Li RK: Differentiation of
allogeneic mesen-chymal stem cells induces immunogenicity and
limits their long-term benefits for myocardial repair. Circulation.
122:2419–2429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blasius AL and Beutler B: Intracellular
toll-like receptors. Immunity. 32:305–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lombardo E, DelaRosa O, Mancheño-Corvo P,
Menta R, Ramírez C and Büscher D: Toll-like receptor-mediated
signaling in human adipose-derived stem cells: Implications for
immunogenicity and immunosuppressive potential. Tissue Eng Part A.
15:1579–1589. 2009. View Article : Google Scholar
|
|
17
|
Cassatella MA, Mosna F, Micheletti A, Lisi
V, Tamassia N, Cont C, Calzetti F, Pelletier M, Pizzolo G and
Krampera M: Toll-like receptor-3-activated human mesenchymal
stromal cells significantly prolong the survival and function of
neutrophils. Stem Cells. 29:1001–1011. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, Liu J, Manuchehrabadi N, Weir MD,
Zhu Z and Xu HH: Umbilical cord and bone marrow mesenchymal stem
cell seeding on macroporous calcium phosphate for bone regeneration
in rat cranial defects. Biomaterials. 34:9917–9925. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fong CY, Chak LL, Biswas A, Tan JH,
Gauthaman K, Chan WK and Bongso A: Human Wharton's jelly stem cells
have unique transcriptome profiles compared to human embryonic stem
cells and other mesenchymal stem cells. Stem Cell Rev. 7:1–16.
2011. View Article : Google Scholar
|
|
20
|
Le Blanc K, Frassoni F, Ball L, Locatelli
F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger
M, et al: Developmental Committee of the European Group for Blood
and Marrow Transplantation: Mesenchymal stem cells for treatment of
steroid-resistant, severe, acute graft-versus-host disease: A phase
II study. Lancet. 371:1579–1586
|
|
21
|
Shi M, Liu ZW and Wang FS:
Immunomodulatory properties and therapeutic application of
mesenchymal stem cells. Clin Exp Immunol. 164:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pevsner-Fischer M, Morad V, Cohen-Sfady M,
Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR and Zipori D:
Toll-like receptors and their ligands control mesenchymal stem cell
functions. Blood. 109:1422–1432. 2007. View Article : Google Scholar
|
|
23
|
Shi Y, Su J, Roberts AI, Shou P, Rabson AB
and Ren G: How mesenchymal stem cells interact with tissue immune
responses. Trends Immunol. 33:136–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaplan JM, Youd ME and Lodie TA:
Immunomodulatory activity of mesenchymal stem cells. Curr Stem Cell
Res Ther. 6:297–316. 2011. View Article : Google Scholar
|
|
25
|
Spaggiari GM, Capobianco A, Becchetti S,
Mingari MC and Moretta L: Mesenchymal stem cell-natural killer cell
interactions: Evidence that activated NK cells are capable of
killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell
proliferation. Blood. 107:1484–1490. 2006. View Article : Google Scholar
|
|
26
|
Li Y and Lin F: Mesenchymal stem cells are
injured by complement after their contact with serum. Blood.
120:3436–3443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nauta AJ, Westerhuis G, Kruisselbrink AB,
Lurvink EG, Willemze R and Fibbe WE: Donor-derived mesenchymal stem
cells are immunogenic in an allogeneic host and stimulate donor
graft rejection in a nonmyeloablative setting. Blood.
108:2114–2120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: Update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Torsvik A and Bjerkvig R: Mesenchymal stem
cell signaling in cancer progression. Cancer Treat Rev. 39:180–188.
2013. View Article : Google Scholar
|
|
30
|
DelaRosa O and Lombardo E: Modulation of
adult mesenchymal stem cells activity by toll-like receptors:
Implications on therapeutic potential. Mediators Inflamm.
2010:8656012010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee
IH, Lin WS, Wu CH, Lin WY and Cheng SM: Mesenchymal stem cells from
human umbilical cord express preferentially secreted factors
related to neuroprotection, neurogenesis, and angiogenesis. PLoS
One. 8:e726042013. View Article : Google Scholar : PubMed/NCBI
|
